retatrutide phase 2 nejm 2023 obesity trial results Achieves Large Weight Decreases in Patients Without Diabetes: TRIUMPH-1 Phase 3 Trial of Semaglutide

As more consumers lose weight and improve their health metrics, insurers can use data-driven approaches to create personalized health plans

SharePrefer us on Google

Its ability to cross the blood-brain barrier means it plays an important role in removing toxins, such as mercury, from the brain and other cells

However, high doses ( 0.5 mg/kg/d) may activate the SREBP-1c pathway, increase liver fat synthesis, and lead to hypertriglyceridemia and fatty liver

GLP-1 is a promising target for the treatment of depression because impaired neurogenesis ability and the reduction of neuronal differentiation leads to multiple depressive pathological symptoms

Instead of three normal meals, you may do better with small food anchors: half a protein shake, a few bites of chicken and rice, a small bowl of soup, or cottage cheese on crackers